Showing results (201-210 of 357) with videos related to
Sort By:
Pageof 36
Psychopharmacology|January 1, 1984
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesiaF Müller-Spahn, M Ackenheil, M Albus, et al.Psychiatry Research|March 1, 1980
Effect of clonidine on growth hormone release in psychiatric patients and controlsN Matussek, M Ackenheil, H Hippius, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1993
3H-spiperone binding capacity in mononuclear cells: a family studyB Bondy, M Ackenheil, M Ertl, et al.Journal of Thrombosis and Haemostasis : JTH|March 23, 2016
Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samplesS Kitchen, Y Katterle, H Beckmann, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Periodic catatonia: a schizophrenic subtype with major gene effect and anticipationG Stöber, E Franzek, K P Lesch, et al.Zentralblatt Fur Chirurgie|May 23, 2013
[Immunological Markers in Organ Transplantation]J H Beckmann, N Heits, F Braun, et al.Psychiatry Research|November 29, 1995
Linkage analysis between pericentrometric markers on chromosome 18 and bipolar disorder: a replication testW Maier, J Hallmayer, P Zill, et al.Neuroimmunomodulation|March 1, 1995
Expression of T cell receptor gamma delta antigens in human brain tissueK H Frenzel, N Müller, D Heidmann, et al.Psychiatria Clinica|January 1, 1981
[HLA, schizophrenias and arthropathies]W F Gattaz, S Kasper, R Ewald, et al.Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1981
Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisitedP Propping, E R Rey, W Friedl, et al.Pageof 36